 |
인쇄하기
취소
|
Institut Pasteur Korea, Sanofi-Aventis to promote tuberculosis drug screening
Institut Pasteur Korea (IPK) announced on October 7 that it has signed a research agreement with Sanofi-Aventis’s Research & Development Center in Toulouse, France for the identification of safe and effective new treatments for patients suffering from tuberculosis.
The partnership would combine IPK’s expertise in high throughput and high content visual screening approaches for the accelerati...
The partnership would combine IPK’s expertise in high throughput and high content visual screening approaches for the accelerati...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.